Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged over 50 years old who have been diagnosed with non-small cell lung cancer (NSCLC), which is a common type of lung cancer.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with lung cancer who have also been diagnosed with any other type of cancer besides non-small cell lung cancer (NSCLC).
- People with lung cancer whose medical records or tissue sample test reports are incomplete or missing information.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nadia Hamdy, PhD, Faculty of pharmacy Ain Shams university
Phone: 00201009570210
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Gene Expression (mRNA levels); Gene Expression (Protein levels); cytotoxic effect; Anti-cancer efficiency of drug-loaded nanoparticles
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.